Table 2.
Demographic and baseline data.
| Parameter: mean/S.D. | GAS group mean/S.D. | SOL group mean/S.D. | Significance level |
|---|---|---|---|
| N = | 12 | 12 | n.s. |
| Age at inclusion | 55.4/12.9 years | 53.1/13.5 years | n.s. |
| Range: | 35–77 years | 22–69 years | |
| Female/male ratio | 3/9 | 5/7 | n.s. |
| Hemorrhage/infarct ratio | 5/7 | 3/9 | n.s |
| Duration since stroke mean/S.D. | 36.1/26.6 months | 48.8/49.5 months | n.s. |
| Range: | 7–108 months | 6–148 months | |
| MAS | 2.9/0.57 | 3.0/0.51 | n.s. |
| WD (m) | 19/13.8 | 16/10.1 | n.s. |
| Gait speed (m/s) | 0.32/0.23 | 0.27/0.17 | n.s. |
Mean, mean value; S.D., standard deviation; GAS group, patients with injections into the gastrocnemius muscle; SOL group, patients with injections into the soleus muscle; WD (m), walking distance during 1 minute; MAS, modified Ashworth scale.